# Multiply Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/multiply-labs

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Website: www.multiplylabs.com/
- Total disclosed funding: $100M
- Latest round: Series B (Oct 6, 2026)
- Investors on record: 11

## About

Based in the US, Multiply Labs, Inc. is a robotics company focused on the manufacturing of precision medicines through advanced automation technologies. Based in San Francisco, US, and founded in 2016 by co-founders Fred Parietti and Alice Melocchi, Multiply Labs, Inc. specializes in developing robotic systems for the industrial-scale manufacturing of gene-modified cell therapies. In October 2026, Multiply Labs, Inc. raised USD 75 million in series B funding led by NantVentures, with participation from AstraZeneca, Teradyne Inc., Lingotto Investment Management, Strange Ventures, Lux Capital, Founders Fund, Casdin Capital, Fifty Years, and Ora Global. Multiply Labs develops advanced robotic systems designed for the manufacturing of precision medicines, particularly gene-modified cell therapies, at an industrial scale. Their technology streamlines production processes in the life sciences sector, offering a modular platform that enables high-throughput capabilities through tailored robotic modules. The company caters to a diverse clientele in biotechnology and pharmaceuticals, focusing on markets in North America, Europe, and Asia. Multiply Labs generates revenue primarily through partnerships and subscription models with biotechnology and pharmaceutical firms. Their transactions revolve around the sale or leasing of robotic manufacturing systems supported by service agreements, including digital process control and maintenance. Their core offerings, such as Digital Quality Control systems and cell therapy capsules, are integrated into clients' production lines, ensuring compliance with Good Manufacturing Practices.

## Funding rounds

- Series B, Oct 6, 2026, $75M — AstraZeneca, Founders Fund, Lux Capital, Teradyne Inc., Casdin Capital, NantVentures, Fifty Years, Lingotto Investment Management, Strange Ventures, Ora Global
- Series A, Apr 5, 2021, $25M — Founders Fund, Lux Capital, Casdin Capital, Garage Capital, Fifty Years

## Investors

- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Series A, Series B
- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Series A, Series B
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A, Series B
- Garage Capital (https://capitalatlas.ai/funds/garage-capital) — Series A
- Fifty Years (https://capitalatlas.ai/funds/fifty-years) — Series A, Series B
- AstraZeneca — Series B
- Teradyne Inc. — Series B
- NantVentures (https://capitalatlas.ai/funds/nantventures) — Series B
- Lingotto Investment Management (https://capitalatlas.ai/funds/lingotto-investment-management) — Series B
- Strange Ventures (https://capitalatlas.ai/funds/strange-ventures) — Series B
- Ora Global (https://capitalatlas.ai/funds/ora-global) — Series B